Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Uncaria rhynchophylla extract** is a botanical preparation derived from the hooks and stems of Uncaria rhynchophylla, a traditional Chinese medicinal plant known as "Gouteng". The primary active components are **indole alkaloids** (notably rhynchophylline, isorhynchophylline, corynoxine, and angustoline), with additional bioactive constituents including flavonoids and triterpenes. The extract has demonstrated a range of pharmacological activities: - **Neuroprotective effects:** Extensively studied for its protective actions in neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Mechanisms include inhibition of amyloid-beta and tau aggregation, activation of mitophagy (via UCHL1), modulation of neurotransmitter systems (notably the serotonergic pathway), and anti-inflammatory properties[2][3][4][5]. - **Vasodilatory/Antihypertensive effects:** Shows vasodilation mediated through the nitric oxide–soluble guanylyl cyclase–cyclic GMP (NO/sGC/cGMP) signaling, prostacyclin (PGI₂), M₃ and β₂ receptors, voltage-gated calcium channels, IP₃-induced intracellular Ca²⁺ release, and potassium channels (except KCa type)[1]. - **Other effects:** Traditional indications include treatment of dizziness, headaches, epilepsy, hypertension, stroke, anxiety, and convulsions. Modern pharmacological investigations also suggest antioxidant and anti-HIV activity[3][5][8]. Typical routes of administration are oral, but intranasal delivery has been studied for targeted brain effects[5]. The extract is mostly considered a herbal supplement rather than an approved pharmaceutical drug in any major regulatory jurisdiction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on uncaria rhynchophylla extract.